Literature DB >> 7757069

Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease.

E Almqvist1, N Spence, K Nichol, S E Andrew, J Vesa, L Peltonen, M Anvret, J Goto, I Kanazawa, Y P Goldberg.   

Abstract

This study addresses genetic factors associated with normal variation of the CAG repeat in the Huntington disease (HD) gene. To achieve this, we have studied patterns of variation of three trinucleotide repeats in the HD gene including the CAG and adjacent CCG repeats as well as a GAG polymorphism at residue 2642 (delta 2642). We have previously demonstrated that variation in the CCG repeat is associated with variation of the CAG repeat length on normal chromosomes. Here we show that differences in the GAG trinucleotide polymorphism at residue 2642 is also significantly correlated with CAG size on normal chromosomes. The B allele which is associated with higher CAG repeat lengths on normal chromosomes is markedly enriched on affected chromosomes. Furthermore, this glutamic acid polymorphism shows significant variation in different ancestries and is absent in chromosomes of Japanese, Black and Chinese descent. Haplotype analysis of both the CCG and delta 2642 polymorphisms have indicated that both are independently associated with differences in CAG length on normal chromosomes. These findings lead to a model for the genetic evolution of new mutations for HD preferentially occurring on normal chromosomes with higher CAG repeat lengths and a CCG repeat length of seven and/or a deletion of the glutamic acid residue at delta 2642. This study also provides additional evidence for genetic contributions to demographic differences in prevalence rates for HD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757069     DOI: 10.1093/hmg/4.2.207

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

1.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

Review 2.  Apoptotic cascades as possible targets for inhibiting cell death in Huntington's disease.

Authors:  Lindsay R Pattison; Mark R Kotter; Dean Fraga; Raphael M Bonelli
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

3.  The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation.

Authors:  Maria do Carmo Costa; Paula Magalhães; Laura Guimarães; Patrícia Maciel; Jorge Sequeiros; Alda Sousa
Journal:  J Hum Genet       Date:  2005-12-22       Impact factor: 3.172

Review 4.  Therapeutic approaches to Huntington disease: from the bench to the clinic.

Authors:  Nicholas S Caron; E Ray Dorsey; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2018-09-21       Impact factor: 84.694

5.  Linkage disequilibrium at the Machado-Joseph disease/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation.

Authors:  G Stevanin; G Cancel; O Didierjean; A Dürr; N Abbas; E Cassa; J Feingold; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

6.  Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation.

Authors:  Irene Paradisi; Alba Hernández; Sergio Arias
Journal:  J Hum Genet       Date:  2007-12-22       Impact factor: 3.172

7.  Sequence-Level Analysis of the Major European Huntington Disease Haplotype.

Authors:  Jong-Min Lee; Kyung-Hee Kim; Aram Shin; Michael J Chao; Kawther Abu Elneel; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Julia A Kaye; Hengameh Zahed; Ian H Kratter; Aaron C Daub; Steven Finkbeiner; Hong Li; Jared C Roach; Nathan Goodman; Leroy Hood; Richard H Myers; Marcy E MacDonald; James F Gusella
Journal:  Am J Hum Genet       Date:  2015-08-27       Impact factor: 11.025

8.  Allele-specific silencing of mutant Huntington's disease gene.

Authors:  Yu Zhang; Joshua Engelman; Robert M Friedlander
Journal:  J Neurochem       Date:  2009-01       Impact factor: 5.372

9.  Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.

Authors:  I Vuillaume; P Vermersch; A Destée; H Petit; B Sablonnière
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

10.  Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes.

Authors:  B Kremer; E Almqvist; J Theilmann; N Spence; H Telenius; Y P Goldberg; M R Hayden
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.